EATG » News

Joint NGO statement on health sustainability in trade and investment agreements

Last week EATG contributed to this joint statement at a Civil Society Dialogue meeting on EU trade policy and Sustainable Development with European Commissioner Malmström (Trade). The reason the subject matters…

Testing Week Statement on Most Affected Populations – Read and Share

Anticipating the upcoming European HIV-Hepatitis Testing Week, an alliance of NGOs has issued the following statement in support of reaching out to and involving most affected populations in HIV and…

EATG signs on call to action for reconsidering primary HIV prevention

Reconsidering primary prevention: Call to action for the global HIV response The world needs a new phase in the evolution of the HIV response – one that reinvigorates prevention by…

ECHOES survey now LIVE: Community Health Workers are invited to provide input!

The ECHOES survey is now LIVE - Community Health Workers who provide sexual health and support services for MSM in the EU and neighbouring countries are invited to participate NOW…

EATG signs on joint statement from civil society organisations on the situation faced by the LGBTI community in Azerbaijan

Mass detention of Azeri LGBTI people– the LGBTI community urgently needs your support Alarming stories of physical violence, verbal abuse, forced medical examinations and detentions of LGBTI people have been…

Hepatitis prevention webinar – Register now!

EATG and the HAND - Hepatitis Access Needs Project would like to invite you to the upcoming webinar on Prevention of Hepatitis B and C that will take place on Monday, 16 October 2017,…

Register now! Webinar on hepatitis B treatment

EATG invites you to a community oriented webinar on Hepatitis B Treatment that will take place on Monday, 18 September 2017, 15:00 – 16:00 CET. The webinar will be held by…

EATG signs on submission to the European Commission on SPC review

Over 30 civil society organisations urge EU to abolish supplementary protection certificates mechanism In an open letter and open submission, thirty-three civil society organisations have called on the European Commission…

Register now! Webinar on regulatory approval of medicines

EATG invites you to a community oriented webinar on the Regulatory Approval Processes of Medicines that will take place on Wednesday, 13 September 2017, 15:00 – 16:00 CET. The webinar will be held…

Register now! Webinar on hepatitis C treatment

EATG invites you to a community oriented webinar on Hepatitis C Treatment that will take place on Tuesday, 12 September 2017, 15:00 – 16:00 CET. The webinar will be held by Prof.…

STEPS IV Cure Workshop in Milan on 24/10/2017

If you are planning to attend the EACS meeting in Milan, Italy (October 25-27), you are invited to apply to the fourth community meeting focused on HIV cure, therapeutic vaccines…

Conference invitation – From HIV testing and linkage to care to the integration of HIV, Hepatitis, TB & STIs

We are pleased to inform you about the European conference “from HIV testing and linkage to care to the integration of HIV, Hepatitis, TB & STIs” that will take place…

Community response to the drug-resistant TB crisis in Europe

On 12-15 May 2017, EATG, in collaboration with the Global TB Community Advisory Board (TB CAB), TBpeople (the Eastern European and Central Asian network of people with experience of TB)…

Register now! Webinar on hepatitis A in Europe

The World Health Organization reports that the recent outbreaks of hepatitis A virus (HAV) mainly affect communities of men having sex with men. We also know that people living with…

All EATG annual reports on one page

No more bulky printed booklets or large PDF files - view and read all EATG annual reports from the last four years on this page: https://www.eatgannualreport.com/ EATG has been working to…

EATG signed on TAG call for TB research for pregnant women

EATG signed a call initiated by Treatment Action Group (TAG, US) for support TB research for pregnant women that is addressed to the Task Force on Research Specific to Pregnant and…

New results from Flash! PrEP in Europe released at IAS 2017

Paris, 26 July: AIDES and PLUS announced to conference attendees from the world over results from the biggest European survey ever to be conducted regarding knowledge, interest and utilisation of…

IAS2017 – Community Paris Declaration published

At the IAS2017 Conference, Paris, 24/07/2017 It is international AIDS conferences that ignite minds and mark turning points in the fight against HIV. This is sometimes a scientific announcement (the arrival…

Lay Summaries workshop: Report now out!

Today the results from clinical trials are usually discussed within the scientific community only and are seldom spread to the general public. With the release of the EU Clinical Trials…

1st Interim Meeting for ESTICOM

EATG participated in the 1st Interim Meeting of the ESTICOM project (http://www.esticom.eu) in Brussels on 17-18/7. ESTICOM is, to some extent, the continuation and revision of the much-used and very useful…

First chronic hepatitis B patient dosed in China in a Phase 1 trial of T101 (Transgene’s TG1050 technology)

STRASBOURG, France, January 17, 2018: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announces that the first patient has been dosed in a Phase 1…

Fresh approach to TB vaccine offers better protection

New vaccine completely protected 41 percent of nonhuman primates; standard vaccine protected none A unique platform that resulted in a promising HIV vaccine has also led to a new, highly…

We found ways to shorten the turnaround time for diagnosing babies with HIV

They say timing is everything. And in sub-Saharan Africa, where roughly a third of untreated HIV infected babies die before they reach the age of one, a timely diagnosis is…

Global summit on IP and access discusses impact of TRIPS-Plus measures on public health

A network of civil society organisations chose the birthplace of the World Trade Organization, Marrakesh, to hold a global summit on intellectual property and access to medicines this week. Part…

WHO position statement on the use of delamanid for MDR-TB

15 January 2018 | Geneva: The World Health Organization (WHO) Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB), following…

TB Europe Coalition releases two new publications

TB Europe Coalition released two new publications - an information brochure about the forthcoming United Nations High-Level Meeting on TB to be held in September this year, and a set…

HIV i-Base: HIV Treatment Bulletin, 5 January 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. The publication starts 2018 with a new look: Shorter… faster… more often… More information here. The online version…

Factors associated with access to HIV testing and primary care among migrants living in Europe: cross-sectional survey

ABSTRACT Background There is a heavy and disproportionate burden of human immunodeficiency virus (HIV) infection among migrant communities living in Europe. Despite this, the published evidence related to HIV testing,…

Hepatitis C treatment highly effective in harder-to-treat HIV coinfected patients, Spanish real-life study shows

Hepatitis C virus (HCV) treatment using direct-acting agents (DAAs) is highly effective and safe in harder-to-treat HIV co-infected patients, Spanish researchers report in AIDS. A sustained virological response (SVR), or…

Hematopoietic stem cell transplantation safe in patients with HIV

An analysis of hematopoietic stem cell transplant recipients in the United States over a 14-year period showed that patients with HIV do not have an increased risk for serious in-hospital…

Investigation questions transparency for failed TB vaccine

The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials. Oxford University scientists developing the MVA85A vaccine, intended…

Ukraine to finance expanded opioid substitution therapy programme

The Government of Ukraine has committed to fund and expand access to opioid substitution therapy (OST) for over 10 000 patients at 178 health-care facilities in 2018. This represents a…

War in Ukraine has escalated HIV spread in the country

Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to…

Johns Hopkins is the first center in the U.S. to be approved for living donor HIV-positive to HIV-positive kidney transplants

Living kidney donors are currently being evaluated for this medical milestone Approximately 122,000 people are on the transplant waiting list in the U.S. at any one time. Allowing HIV-positive living…

HIV does not increase aging-related brain changes in patients on ART

Researchers said they found no evidence that HIV accelerates aging-related brain changes over a 2-year period in middle-aged patients on successful ART. “This provides reassurance that, with virological suppression, [people…

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

Low-level HIV viral load, above the limit of detection, is an important warning signal for future treatment failure and World Health Organization guidelines on spotting treatment failure need to be…

Mother-to-child HIV transmission higher when mother has other STIs

A new study confirms that HIV-infected pregnant women have a higher risk of transmitting the HIV to their infants if the mothers also have another sexually transmitted infection. The research…

One-time routine HIV screening at age 25 optimal with no risk factors

For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective, according to a study published in the Journal…

Positive LAM results predict mortality in children with HIV

Children with HIV in Kenya whose urine samples tested positive for lipoarabinomannan, or LAM — a biomarker of tuberculosis — had a nearly fivefold increased risk for mortality compared with…

Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

Two new qualitative studies from Toronto shed light on how stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience of taking it. In the first, young gay men…